On December 1st, the final conference of HAPPY PATIENT took place in Barcelona, bringing together nearly 50 people, including project partners and professionals from the academic, health, and research fields. It served as a gathering point to address the public health issue of antibiotic resistance on a European and global...
In Europe, nearly 35,000 people die each year due to antimicrobial resistance, mainly caused by inappropriate antibiotic use, as reflected in data from the European Centre for Disease Prevention and Control. This is a global public health problem, which the World Health Organization (WHO) has already identified as one of...
The HAPPY PATIENT team is joining World Antibiotic Awareness Week. Specifically, Maarten Lambert and Katja Taxis have been invited to an event organized by the International Pharmaceutical Federation (FIP). This Monday, Lambert was one of five panelists presenting some results of the HAPPY PATIENT project in a webinar with around...
The coordinator of HAPPY PATIENT, Dr. Carl Llor, researcher at IDIAP Jordi Gol and family doctor, explains in this interview his role in the project and everything that working on it for three years alongside professionals from around Europe has brought to him. HAPPY PATIENT emerges as a standout initiative...
In Europe, around 35,000 individuals die annually to antimicrobial resistance, primarily stemming from the inappropriate use of antibiotics. This poses a public health dilemma necessitating immediate actions to safeguard the well-being of the population. In this context, HAPPY PATIENT has played a role in enhancing the correct prescription and dispensation...
On June 8th and 9th, the partners of the HAPPY PATIENT project gathered in Copenhagen to assess the progress of this project, which started in 2021 and will run until the end of this year, 2023. Around thirty professionals from different parts of Europe gathered at the University of Copenhagen...
Last week, the Research Institute in Primary Healthcare IDIAPJGol and the Catalan Institute of Health (ICS) presented their Annual Awards for "Research in Primary Health Care IDIAPJGol-ICS". A total of 23 researchers were awarded in different categories.
The European Commission has recently put forth a proposal to amend the EU pharmaceutical legislation on April 26, 2023 (available at https://health.ec.europa.eu/system/files/2023-04/com_2023_193_1_act_en.pdf). This proposed revision aims to establish a unified market for medicines across all EU member states, thereby promoting greater accessibility to novel and effective drugs while also tackling...
The WHO has called on governments and pharmaceutical companies to invest in research and development of new antibiotics and has also recommended that antibiotics be used more judiciously to prevent the emergence of drug-resistant bacteria.
Global increase in antimicrobial resistance and complexity of infectious disease make it essential to establish Antimicrobial Use Optimization Programs (PROA) in the community and hospital areas. These programs have the objective of optimizing prescription of antibiotics, guaranteeing optimal clinical results, minimizing adverse effects derived from their use, controlling the appearance...
